H. Bailey

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.

T. Nielsen, E. Thompson, C. Sotiriou, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

A 17‐Gene Genomic Prostate Score Assay Provides Independent Information on Adverse Pathology in the Setting of Combined Multiparametric Magnetic Resonance Imaging Fusion Targeted and Systematic Prostate Biopsy

P. Febbo, S. Raman, D. Elashoff, 2018, The Journal of urology.

Expression of CD44s, CD44v6, and Hyaluronan Across the Spectrum of Normal-hyperplasia-carcinoma in Breast

H. Bailey, A. Paulino, A. Afify, 2008, Applied immunohistochemistry & molecular morphology : AIMM.

Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast Cancer.

E. Perez, E. Thompson, F. Baehner, 2016, JAMA oncology.

12-Gene Recurrence Score Assay Stratifies the Recurrence Risk in Stage II/III Colon Cancer With Surgery Alone: The SUNRISE Study.

E. Oki, T. Yamanaka, Y. Ohashi, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study

N. Taira, H. Iwata, Y. Ohashi, 2018, Breast Cancer Research and Treatment.

Molecular characterization of breast cancer needle core biopsy specimens by the 21‐gene Breast Recurrence Score test

C. Mies, F. Baehner, H. Bailey, 2020, Journal of surgical oncology.

12-Gene Recurrence Score Assay Stratifies the Recurrence Risk in Stage II/III Colon Cancer With Surgery Alone: The SUNRISE Study.

E. Oki, T. Yamanaka, Y. Ohashi, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abstract S1-06: Stromal tumor-infiltrating lymphocytes(S-TILs): In the alliance N9831 trial S-TILs are associated with chemotherapy benefit but not associated with trastuzumab benefit

E. Perez, E. Thompson, S. Badve, 2015 .